171 related articles for article (PubMed ID: 30760521)
1. Deoxyribozymes as Catalytic Nanotherapeutic Agents.
Khachigian LM
Cancer Res; 2019 Mar; 79(5):879-888. PubMed ID: 30760521
[TBL] [Abstract][Full Text] [Related]
2. Deoxyribozymes: cleaving a path to clinical trials.
Dass CR
Trends Pharmacol Sci; 2004 Aug; 25(8):395-7. PubMed ID: 15276705
[TBL] [Abstract][Full Text] [Related]
3. DNAzyme-based therapeutics for cancer treatment.
Fu S; Sun LQ
Future Med Chem; 2015; 7(13):1701-7. PubMed ID: 26381244
[TBL] [Abstract][Full Text] [Related]
4. Zn
Moon WJ; Yang Y; Liu J
Chembiochem; 2021 Mar; 22(5):779-789. PubMed ID: 33007113
[TBL] [Abstract][Full Text] [Related]
5. Theranostic DNAzymes.
Zhou W; Ding J; Liu J
Theranostics; 2017; 7(4):1010-1025. PubMed ID: 28382172
[TBL] [Abstract][Full Text] [Related]
6. Molecular Features and Metal Ions That Influence 10-23 DNAzyme Activity.
Rosenbach H; Victor J; Etzkorn M; Steger G; Riesner D; Span I
Molecules; 2020 Jul; 25(13):. PubMed ID: 32646019
[TBL] [Abstract][Full Text] [Related]
7. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis.
Lu ZX; Ye M; Yan GR; Li Q; Tang M; Lee LM; Sun LQ; Cao Y
Cancer Gene Ther; 2005 Jul; 12(7):647-54. PubMed ID: 15803142
[TBL] [Abstract][Full Text] [Related]
8. A complex RNA-cleaving DNAzyme that can efficiently cleave a pyrimidine-pyrimidine junction.
Lam JC; Withers JB; Li Y
J Mol Biol; 2010 Jul; 400(4):689-701. PubMed ID: 20630470
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes).
Wu Y; Yu L; McMahon R; Rossi JJ; Forman SJ; Snyder DS
Hum Gene Ther; 1999 Nov; 10(17):2847-57. PubMed ID: 10584930
[TBL] [Abstract][Full Text] [Related]
10. In vitro selection of RNA-cleaving DNAzymes for bacterial detection.
Zhang W; Feng Q; Chang D; Tram K; Li Y
Methods; 2016 Aug; 106():66-75. PubMed ID: 27017912
[TBL] [Abstract][Full Text] [Related]
11. Nucleic acid-cleaving catalytic DNA for sensing and therapeutics.
Zimmermann AC; White IM; Kahn JD
Talanta; 2020 May; 211():120709. PubMed ID: 32070594
[TBL] [Abstract][Full Text] [Related]
12. DNA Catalysis: The Chemical Repertoire of DNAzymes.
Hollenstein M
Molecules; 2015 Nov; 20(11):20777-804. PubMed ID: 26610449
[TBL] [Abstract][Full Text] [Related]
13. Developing fluorogenic RNA-cleaving DNAzymes for biosensing applications.
Ali MM; Aguirre SD; Mok WW; Li Y
Methods Mol Biol; 2012; 848():395-418. PubMed ID: 22315083
[TBL] [Abstract][Full Text] [Related]
14. DNAzyme technology and cancer therapy: cleave and let die.
Dass CR; Choong PF; Khachigian LM
Mol Cancer Ther; 2008 Feb; 7(2):243-51. PubMed ID: 18281510
[TBL] [Abstract][Full Text] [Related]
15. DNAzymes: from creation in vitro to application in vivo.
Achenbach JC; Chiuman W; Cruz RP; Li Y
Curr Pharm Biotechnol; 2004 Aug; 5(4):321-36. PubMed ID: 15320762
[TBL] [Abstract][Full Text] [Related]
16. In vitro selection, characterization, and application of deoxyribozymes that cleave RNA.
Silverman SK
Nucleic Acids Res; 2005; 33(19):6151-63. PubMed ID: 16286368
[TBL] [Abstract][Full Text] [Related]
17. DNAzymes: cutting a path to a new class of therapeutics.
Khachigian LM
Curr Opin Mol Ther; 2002 Apr; 4(2):119-21. PubMed ID: 12044032
[TBL] [Abstract][Full Text] [Related]
18. Discovery and Biosensing Applications of Diverse RNA-Cleaving DNAzymes.
Liu M; Chang D; Li Y
Acc Chem Res; 2017 Sep; 50(9):2273-2283. PubMed ID: 28805376
[TBL] [Abstract][Full Text] [Related]
19. Integrating Deoxyribozymes into Colorimetric Sensing Platforms.
Chang D; Zakaria S; Deng M; Allen N; Tram K; Li Y
Sensors (Basel); 2016 Dec; 16(12):. PubMed ID: 27918487
[TBL] [Abstract][Full Text] [Related]
20. Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.
Yu X; Yang L; Cairns MJ; Dass C; Saravolac E; Li X; Sun LQ
Oncotarget; 2014 Oct; 5(19):9039-48. PubMed ID: 25344863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
